Skip to main content
Clinical Trials/NCT04331106
NCT04331106
Unknown
Not Applicable

Online-based Survey of the Anxiety Associated With the COVID-19 Pandemic in the General Population in Germany

Charite University, Berlin, Germany1 site in 1 country7,500 target enrollmentMarch 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anxiety Related to the COVID-19 Pandemic
Sponsor
Charite University, Berlin, Germany
Enrollment
7500
Locations
1
Primary Endpoint
Characteristics of COVID-19-related anxiety
Last Updated
5 years ago

Overview

Brief Summary

The study aims to systematically examine various aspects of the anxiety associated with the COVID-19 pandemic in Germany. The data collection is carried out online with longitudinal repeated measurements.

Detailed Description

The COVID-19 pandemic is currently one of the greatest challenges for numerous countries - also for Germany. In addition to its somatic and economic consequences, the psychological dimension of the Coronavirus pandemic is discussed increasingly and is visible in public life - e.g. in the "pandemic-caused experience of threat", "loss of control" and "panic" of multiple people. The study examines the phenomenon of this "corona-related anxiety" in terms of epidemiological, clinical and psychosocial characteristics. It is investigated how "corona anxiety" affects people who already have an anxiety disorder or other mental illnesses as well as formerly mentally healthy people. It is also examined how media reporting and personal consequences of COVID-19 are connected with corona-related anxiety and if there is a need for therapeutic support regarding corona-related anxiety. To answer these questions a longitudinal online survey targeting the general population in Germany is carried out. The survey takes place all three weeks as long as the pandemic lasts and ends with one follow-up one year later.

Registry
clinicaltrials.gov
Start Date
March 27, 2020
End Date
April 2022
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Antonia Bendau

Principal Investigator

Charite University, Berlin, Germany

Eligibility Criteria

Inclusion Criteria

  • informed consent was given
  • able to complete the questionnaire in German
  • country of residence: Germany

Exclusion Criteria

  • if at least one of the inclusion criteria is not met

Outcomes

Primary Outcomes

Characteristics of COVID-19-related anxiety

Time Frame: 1 day

To investigate specific fears regarding the COVID-19 pandemic 9 self created items are used. Values ranging from 1 to 6, higher scores indicate a worse outcome.

COVID-19-related anxiety symptoms

Time Frame: 1 day

Modified German version of the DSM-5 Severity-Measure-For-Specific-Phobia-Adult-Scale by Beesdo-Baum et al. (2014). 10 items, values ranging from 1 to 5, higher scores indicate a worse outcome. The Scale was adapted to anxiety symptoms related to COVID-19.

Secondary Outcomes

  • Media reporting(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • Self-efficacy and coping with COVID-19(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • Consequences of COVID-19 in the last three weeks.(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • General Illness Attitude(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • Ultra-brief screening scale for anxiety and depression(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • Change in characteristics of COVID-19-related anxiety(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)
  • Change in COVID-19-related anxiety symptoms(baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months)

Study Sites (1)

Loading locations...

Similar Trials